With more people staying on therapy longer, new indications on the rise and a strong pipeline ahead, employers need to take a sharper, more strategic approach to managing this drug class, she said
Across 26,436 total participants, they identified 252 different serious adverse events and calculated the relative risk for each one
Its safety profile is similar to existing incretin-based therapies, making it a particularly promising candidate for obesity, type 2 diabetes, and related metabolic conditions
In June, the FDA warned consumers that off-brand forms of Ozempic and Wegovy could be unsafe
Instead of pushing to the full weight-loss dose, some patients start at a low dose, just enough to nudge the metabolic and inflammatory pathways, without major appetite suppression